Announcement of Resolutions of Anxu Biotech's 2023 Annual General Meeting of Shareholders
Legal Opinion of Shanghai AllBright Law Firm on An Xu Biotech's 2023 Annual General Meeting of Shareholders
Anxu Biotech's 2023 Annual General Meeting of Shareholders Meeting Materials
Notice on amending the “Articles of Association” and completing registration procedures for industrial and commercial changes
Anxu Biotech Board of Directors Rules of Procedure (202404)
Special Meeting System for Independent Directors (202404)
Announcement on Launching Forward Foreign Exchange Settlement and Foreign Exchange Derivatives Business
Announcement on preparation for impairment of assets accrued in 2023
Notice on convening the 2023 Annual General Meeting of Shareholders
Announcement on the 2024 “Improve Quality, Increase Efficiency, and Focus on Rewards” Action Plan
Report of the Audit Committee of the Board of Directors on the performance of supervisory duties by accounting firms in 2023
2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors in 2023
Special report of the board of directors on the self-inspection of the independence of independent directors
Announcement of Resolutions of Anxu Biotech\'s 2024 First Extraordinary General Meeting of Shareholders
Legal Opinion of Shanghai AllBright Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of An Xu Biotech
Anxu Biotech 2024 First Extraordinary General Meeting of Shareholders Meeting Information
An Xu Biotech\'s announcement on the adjustment of the members of the company\'s 2nd Audit Committee
Anxu Biotech Board Audit Committee Working Rules (revised January 2024).
Anxu Biotech Board Nomination Committee Working Rules (Revised in January 2024)
No Data